# DENDREON CORP

DENDREON CORP is a company headquartered in Seattle, WA, United States.

## Company overview

- **Legal name:** DENDREON CORP
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** Seattle, WA, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0001107332

## About

DENDREON CORP is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001107332, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2014-03-03, it reported annual revenue of USD 283,746,000; net income of USD -296,804,000; total assets of USD 434,401,000 for the fiscal period ended 2013-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2013 (period ended 2013-12-31)

- **Revenue:** $283.7M (USD 283,746,000)
- **Net income:** -$296.8M (USD -296,804,000)
- **Total assets:** $434.4M (USD 434,401,000)
- **Cash and equivalents:** $92.5M (USD 92,530,000)
- **Operating cash flow:** -$217.4M (USD -217,387,000)

### FY2012 (period ended 2012-12-31)

- **Revenue:** $325.5M (USD 325,530,000)
- **Net income:** -$393.6M (USD -393,610,000)
- **Total assets:** $721.1M (USD 721,119,000)
- **Cash and equivalents:** $188.4M (USD 188,408,000)
- **Operating cash flow:** -$208.7M (USD -208,720,000)

### FY2011 (period ended 2011-12-31)

- **Revenue:** $341.6M (USD 341,613,000)
- **Net income:** -$337.8M (USD -337,806,000)
- **Total assets:** $1.0B (USD 1,001,491,000)
- **Cash and equivalents:** $427.1M (USD 427,100,000)
- **Operating cash flow:** -$242.3M (USD -242,295,000)

### FY2010 (period ended 2010-12-31)

- **Revenue:** $48.1M (USD 48,057,000)
- **Net income:** -$439.5M (USD -439,480,000)
- **Total assets:** $604.0M (USD 603,953,000)
- **Cash and equivalents:** $133.0M (USD 132,995,000)
- **Operating cash flow:** -$267.5M (USD -267,468,000)
- **Later filings:** Operating cash flow: shown as originally filed; later filings report different values for the same periods.

## Recent SEC filings

- Form 8-K — filed 2015-06-10 — period 2015-06-10 — FORM 8-K
- Form 8-K — filed 2015-06-03 — period 2015-06-02 — 8-K
- Form 8-K — filed 2015-06-02 — period 2015-06-02 — 8-K
- Form 8-K — filed 2015-05-21 — period 2015-05-20 — FORM 8-K
- Form 8-K — filed 2015-04-21 — period 2015-04-20 — 8-K
- Form 8-K — filed 2015-04-17 — period 2015-04-14 — 8-K
- Form 8-K — filed 2015-04-08 — period 2015-03-23 — FORM 8-K
- Form 8-K — filed 2015-03-25 — period 2015-03-20 — FORM 8-K
- Form 8-K — filed 2015-03-11 — period 2015-03-10 — 8-K
- Form 8-K — filed 2015-03-06 — period 2015-01-09 — 8-K
- Form 8-K — filed 2015-02-27 — period 2015-02-23 — FORM 8-K
- Form 8-K — filed 2015-02-23 — period 2015-02-19 — 8-K

---

Updated: 2026-10-23T20:06:36Z

Canonical page: https://altss.com/profile/dendreon-corp

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology